Xing‐Kai Qian

680 total citations
31 papers, 568 citations indexed

About

Xing‐Kai Qian is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Xing‐Kai Qian has authored 31 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Xing‐Kai Qian's work include Peptidase Inhibition and Analysis (6 papers), Neuropeptides and Animal Physiology (6 papers) and Computational Drug Discovery Methods (5 papers). Xing‐Kai Qian is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Neuropeptides and Animal Physiology (6 papers) and Computational Drug Discovery Methods (5 papers). Xing‐Kai Qian collaborates with scholars based in China, United States and India. Xing‐Kai Qian's co-authors include Li‐Wei Zou, Pramod Upadhyaya, Fekadu Kassie, Guang‐Bo Ge, Tamene Melkamu, Ling Yang, Qiang Jin, Guangbo Ge, Xiaoze Bao and Ping Wang and has published in prestigious journals such as Chemistry - A European Journal, Biosensors and Bioelectronics and Organic Letters.

In The Last Decade

Xing‐Kai Qian

29 papers receiving 560 citations

Peers

Xing‐Kai Qian

PHARM

ONCOL

EDM

Sze Wei Leong Malaysia

Young Taek Han South Korea

Alfons Nonell‐Canals Spain

Riyaz Syed India

Yi Li Wong Malaysia

Shengrong Li China

Alfonso Trezza Italy

Napat Songtawee Thailand

Wang-Fun Fong Hong Kong

Susan Petusky United States

Sze Wei Leong Malaysia

Xing‐Kai Qian

231 ×0.9

195 ×1.4

75 ×0.7

PHARM

79 ×1.0

ONCOL

58 ×0.9

EDM

Citations per year, relative to Xing‐Kai Qian Xing‐Kai Qian (= 1×) peers Sze Wei Leong

Countries citing papers authored by Xing‐Kai Qian

Since Specialization

Citations

This map shows the geographic impact of Xing‐Kai Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing‐Kai Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing‐Kai Qian more than expected).

Fields of papers citing papers by Xing‐Kai Qian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing‐Kai Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing‐Kai Qian. The network helps show where Xing‐Kai Qian may publish in the future.

Co-authorship network of co-authors of Xing‐Kai Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Xing‐Kai Qian. A scholar is included among the top collaborators of Xing‐Kai Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing‐Kai Qian. Xing‐Kai Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zuo, Yu, Siyuan Yang, Xing‐Kai Qian, & Kun Liu. (2025). Analysis of hub genes temporal dynamics in cardiac ischemia/reperfusion injury: a bioinformatics and experimental study. Frontiers in Physiology. 16. 1668586–1668586.

Wang, Dandan, et al.. (2024). Pyrazolone compounds could inhibit CES1 and ameliorates fat accumulation during adipocyte differentiation. Bioorganic Chemistry. 150. 107536–107536. 2 indexed citations

Li, Hao, Xiaodong Li, Chunyang Yu, et al.. (2024). Activity-based NIR specific fluorescent probe reveals the abnormal elevation of prolyl endopeptidase in hippocampus during Alzheimer's disease progression. Sensors and Actuators B Chemical. 417. 136071–136071. 6 indexed citations

Zhang, Jing, Yi‐Ming Fan, Hong Huo, et al.. (2024). A sensitive fluorescence assay of serum dipeptidyl peptidase IV activity to predict the suitability of its inhibitors in patients with type 2 diabetes mellitus. Journal of Pharmaceutical and Biomedical Analysis. 249. 116382–116382.

Yang, Siyuan, Honghong Ma, Jing Zhou, et al.. (2024). Discovery of natural anthraquinones as potent inhibitors against pancreatic lipase: structure-activity relationships and inhibitory mechanism. Journal of Enzyme Inhibition and Medicinal Chemistry. 39(1). 2398561–2398561. 3 indexed citations

Wu, Hongkun, Xing‐Kai Qian, Xueting Wang, et al.. (2024). Exosomes derived from mesenchymal stem cells ameliorate impaired glucose metabolism in myocardial Ischemia/reperfusion injury through miR-132-3p/PTEN/AKT pathway. Cell Cycle. 23(17-20). 893–912. 2 indexed citations

Wu, Hongkun, Xing‐Kai Qian, & Guiyou Liang. (2023). The Role of Small Extracellular Vesicles Derived from Mesenchymal Stromal Cells on Myocardial Protection: a Review of Current Advances and Future Perspectives. Cardiovascular Drugs and Therapy. 38(6). 1111–1122. 2 indexed citations

Wang, Dandan, Xing‐Kai Qian, Hongxin Li, et al.. (2021). Sensing and imaging of exosomal CD26 secreted from cancer cells and 3D colorectal tumor model using a novel near-infrared fluorogenic probe. Materials Science and Engineering C. 130. 112472–112472. 11 indexed citations

Qian, Xing‐Kai, Jing Zhang, Hongying Ma, et al.. (2021). Discovery of pyrazolones as novel carboxylesterase 2 inhibitors that potently inhibit the adipogenesis in cells. Bioorganic & Medicinal Chemistry. 40. 116187–116187. 19 indexed citations

10.

Qian, Xing‐Kai, et al.. (2021). Differences in susceptibility of HT‐29 and A549 cells to statin‐induced toxicity: An investigation using high content screening. Journal of Biochemical and Molecular Toxicology. 35(4). e22699–e22699. 2 indexed citations

11.

Qian, Xing‐Kai, Anqi Wang, Li‐Wei Zou, et al.. (2021). Accurate Assessment and Tracking the Process of Liver-Specific Injury by the Residual Tissue Activity of Carboxylesterase 1 and Dipeptidyl Peptidase 4. Engineering. 19. 153–165. 3 indexed citations

12.

Qian, Xing‐Kai, et al.. (2020). Construction and application of a high-content analysis for identifying human carboxylesterase 2 inhibitors in living cell system. Analytical and Bioanalytical Chemistry. 412(11). 2645–2654. 16 indexed citations

13.

Zhao, Xiaohua, Hong Ma, Haiyi Wang, et al.. (2020). Theophylline Acetaldehyde as the Initial Product in Doxophylline Metabolism in Human Liver. Drug Metabolism and Disposition. 48(5). 345–352. 12 indexed citations

14.

Wang, Ping, Yangliu Xia, Li‐Wei Zou, et al.. (2017). An Optimized Two‐Photon Fluorescent Probe for Biological Sensing and Imaging of Catechol‐O‐Methyltransferase. Chemistry - A European Journal. 23(45). 10800–10807. 43 indexed citations

15.

Zou, Li‐Wei, Ping Wang, Xing‐Kai Qian, et al.. (2016). A highly specific ratiometric two-photon fluorescent probe to detect dipeptidyl peptidase IV in plasma and living systems. Biosensors and Bioelectronics. 90. 283–289. 62 indexed citations

16.

Qian, Xing‐Kai, Ping Wang, Yangliu Xia, et al.. (2016). A highly selective fluorescent probe for sensing activities of catechol- O -methyltransferase in complex biological samples. Sensors and Actuators B Chemical. 231. 615–623. 14 indexed citations

17.

Song, Jian, et al.. (2015). Combinations of indole-3-carbinol and silibinin suppress inflammation-driven mouse lung tumorigenesis by modulating critical cell cycle regulators. Carcinogenesis. 36(6). 666–675. 31 indexed citations

18.

Qian, Xing‐Kai, et al.. (2014). cDNA-AFLP transcriptional profiling reveals genes expressed during flower development in Oncidium Milliongolds. Genetics and Molecular Research. 13(3). 6303–6315. 2 indexed citations

19.

Melkamu, Tamene, Xing‐Kai Qian, Pramod Upadhyaya, Maeve O’Sullivan, & Fekadu Kassie. (2013). Lipopolysaccharide Enhances Mouse Lung Tumorigenesis. Veterinary Pathology. 50(5). 895–902. 57 indexed citations

20.

Melkamu, Tamene, Melissa M. Schutten, Xing‐Kai Qian, et al.. (2011). Enhanced inhibition of lung adenocarcinoma by combinatorial treatment with indole-3-carbinol and silibinin in A/J mice. Carcinogenesis. 32(4). 561–567. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact